These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meta-analysis of injectable gold in rheumatoid arthritis. Clark P; Tugwell P; Bennett K; Bombardier C J Rheumatol; 1989 Apr; 16(4):442-7. PubMed ID: 2664167 [TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and the clinical outcome of gold therapy in rheumatoid arthritis. Lewis D; Capell HA; McNeil CJ; Smith WE; Brown DH J Rheumatol; 1984 Feb; 11(1):111-2. PubMed ID: 6422040 [No Abstract] [Full Text] [Related]
4. [Treatment of rheumatoid arthritis by a single daily dose of levamisole. A comparative trial with gold salts]. Ristori JM; Bussiere JL; Sauvezie B; Epifanie JL; Rampon S Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):57-62. PubMed ID: 6342114 [No Abstract] [Full Text] [Related]
5. Multiple-outcome meta-analysis of clinical trials. Berkey CS; Anderson JJ; Hoaglin DC Stat Med; 1996 Mar; 15(5):537-57. PubMed ID: 8668877 [TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters. Lund B; Graae A; Sonne I; Andersen RB Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933 [TBL] [Abstract][Full Text] [Related]
7. Gold in rheumatoid arthritis: standard, substitute or sham? Harth M J Rheumatol; 1993 May; 20(5):771-3. PubMed ID: 8101568 [No Abstract] [Full Text] [Related]
9. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis. Williams HJ J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928 [TBL] [Abstract][Full Text] [Related]
10. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience. Kahan A; Menkès CJ Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911 [TBL] [Abstract][Full Text] [Related]
11. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)]. Tsvetkova ES Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779 [TBL] [Abstract][Full Text] [Related]
12. Organic gold compounds in the treatment of rheumatoid arthritis. Rooney TW; Furst DE Iowa Med; 1985 Feb; 75(2):74-7. PubMed ID: 3918952 [No Abstract] [Full Text] [Related]
13. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis]. Atakhodzhaeva ZA; Sigidin IaA Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906 [TBL] [Abstract][Full Text] [Related]
14. What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols? Pincus T; Stein CM J Rheumatol; 1995 Sep; 22(9):1611-7. PubMed ID: 8523331 [No Abstract] [Full Text] [Related]
15. Meta-analysis of randomized clinical trials in cancer. Buyse M Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848 [No Abstract] [Full Text] [Related]
16. [Gold therapy of rheumatic diseases]. Berndt H Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970 [No Abstract] [Full Text] [Related]
17. Controversies in the analysis of longterm clinical trials of slow acting drugs. Bombardier C; Tugwell P J Rheumatol; 1985 Jun; 12(3):403-5. PubMed ID: 4045839 [No Abstract] [Full Text] [Related]
18. Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis. Smolen JS; Aletaha D Nat Clin Pract Rheumatol; 2008 Jun; 4(6):296-7. PubMed ID: 18461061 [No Abstract] [Full Text] [Related]
19. [Clinical studies with salazopyrine--consequences and perspectives]. Zeidler H Z Rheumatol; 1987; 46(2):59-66. PubMed ID: 2885985 [TBL] [Abstract][Full Text] [Related]